Hostname: page-component-7b7567c8c-lpg2g Total loading time: 0 Render date: 2026-11-15T22:53:15.105Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychotropics and hyponatraemia

Published online by Cambridge University Press:  02 January 2018

Robyn McAskill and
David Taylor
Robyn McAskill
Affiliation:
Maudsley Hospital, Denmark Hill, London SE5 8AZ
David Taylor*
Affiliation:
Maudsley Hospital, Denmark Hill, London SE5 8AZ
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Hyponatraemia is usually defined as a serum sodium concentration below 135 mmol/1. The condition is rarely symptomatic until serum sodium falls below 120 mmol/1 and symptoms are more usually associated with values around 110 mmol/1. These symptoms include confusion and restlessness, progressing to drowsiness, myoclonic jerks, generalised convulsions and eventually coma. In a general hospital population about 1% of patients develop hyponatraemia (Rutsky, 1992), whereas in psychiatric patients the prevalence has been reported to range from 3.3% to 12.2% (Ohsawa et al, 1992).

Information

Type
Drug Information Quarterly
Information
Psychiatric Bulletin , Volume 21 , Issue 1 , January 1997, pp. 33 - 35
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1997 The Royal College of Psychiatrists

References

Alexander, R. C., Karp, B. I., Thompson, S., et al (1991) A double blind placebo-controlled trial of demeclocycline treatment of polydipsia-hyponatraemia in chronically psychotic patients. Biological Psychiatry, 30, 417–420.Google Scholar
Committee on Safety of Medicines (1994) Antidepressant-induced hyponatremia. Current Problems in Pharmaco-vigilance, 20, 5–6.Google Scholar
Dubovsky, S. L., Grabon, S., Berl, T., et al (1973) Syndrome of inappropriate secretion of antidiuretic hormone with exacerbated psychosis. Annals of Internal Medicine, 79, 551–554.Google Scholar
Flint, A. J., Crosby, J. & Genik, J. L. (1996) Recurrent hyponatraemia associated with fluoxetine and paroxetine. American Journal of Psychiatry, 153, 134.Google Scholar
Glusac, E., Patel, H., Josef, N. C., et al (1990) Polydipsia and hyponatraemia induced by multiple neuroleptics but not molindone. Canadian Journal of Psychiatry, 35, 268–269.Google Scholar
Goddard, C. & Paton, C. (1992) Hyponatraemia associated with paroxetine. British Medical Journal 305, 1332.CrossRefGoogle ScholarPubMed
Jackson, C., Carson, W., Markowitz, J., et al (1995) SIADH associated with fluoxetine and sertraline therapy. American Journal of Psychiatry, 152, 809–810.Google Scholar
Leadbetter, R. A. & Shutty, M. S. (1994) Differential effects of neuroleptics and clozapine on polydipsia and intermittent hyponatraemia. Journal of Clinical Psychiatry, 55[Suppl B], 110–113.Google Scholar
Ogilvie, A. D. & Croy, M. F. (1992) Clozapine and hyponatraemia. Lancet 340, 672.CrossRefGoogle ScholarPubMed
Ohsawa, H., Kishimoto, T., Hirai, M., et al (1992) An epidemiological study on hyponatraemia in psychiatric patients in mental hospitals in Nara Pretecture. Japanese Journal of Psychiatry and Neurology, 46, 883–889.Google Scholar
Rutsky, E. A. (1992) Water, electrolyte, mineral and acid-base metabolism. In Merk Manual of Diagnosis and Therapy (eds R. B. Berkow & A. J. Fletcher), pp. 991–995. New Jersey: Merk & Co. Inc.Google Scholar
Schwartz, W., Bennett, S., Curelop, S., et al (1957) A syndrome of renal sodium loss and hyponatraemia probably resulting from inappropriate secretion of antidiuretic hormone. American Journal of Medicine, 23, 529–542.Google Scholar
Staab, Y. P., Yerkes, S. A., Cheney, E. M., et al (1990) Transient SIADH associated with fluoxetine therapy. American Journal of Psychiatry, 147, 1569–1570.Google Scholar
Thomas, A. & Verbalis, J. G. (1995) Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion associated with drug therapy in psychiatric patients. CNS Drugs, 4, 357–369.Google Scholar
Thornton, S. L. & Resch, D. S. (1995) SIADH associated with sertraline therapy. American Journal of Psychiatry, 152, 809.Google Scholar
Vishwanath, B. M., Navalgund, A. A., Cusano, W., et al (1991) Fluoxetine as a cause of SIADH. American Journal of Psychiatry, 148, 542–543.Google Scholar
Wakefield, T. & Colls, I. (1996). Clozapine treatment of a schizophrenic patient with polydipsia and hyponatraemia. American Journal of Psychiatry, 153, 445–446.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.